חזרה לתוצאות החיפוש

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Pancreatic Ductal Adenocarcinoma (PDAC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Helios CR Inc./RadNet, Cerritos, California, United States

    Contact: Study coordinator (Sabrina Mora) · Sabrina.mora@heliosclinical.com · 562-693-4477
    Contact: Study coordinator (Alexis Velasco) · alexis.velasco@heliosclinical.com
    Contact: Principal Investigator (Omkar Marathe, M.D.)

  • City of Hope National Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Miranda Qian) · lqian@coh.org · (626) 218-3533
    Contact: Principal Investigator (Yufei Liu, M.D, Ph.D)

  • Hoag Memorial Hospital, Irvine, California, United States

    Contact: Study coordinator (Beth Thomsen) · Beth.thomsen@hoag.org · 949-557-0285
    Contact: Principal Investigator (Gary Ulaner, MD)

  • UCLA, Los Angeles, California, United States

    Contact: Study coordinator (Steven Stokes) · SStokes@mednet.ucla.edu · 310 206-7436
    Contact: Principal Investigator (Mark Girgis, MD)

  • Stanford University, Stanford, California, United States

    Contact: Study coordinator (Kavin Tamizhmani) · ktamizhm@stanford.edu · (650)-497-6046
    Contact: Principal Investigator (Matteo Novello, MD)

  • Moffit Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Jacqueline Guillermo Adams) · Jacqueline.GuillermoAdams@moffitt.org · 813-745-2468
    Contact: Principal Investigator (Ghassan El-Haddad, MD)

  • Indiana University Health University Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Eric Grubbs) · eegrubbs@iu.edu · (317) 274-2584
    Contact: Principal Investigator (Cindy Yuan, MD PhD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Isabelle Lin) · ilin4@mgh.harvard.edu · 617-643-6837
    Contact: Principal Investigator (Shadi Esfahani, MD)

  • UMass/Shields, Worcester, Massachusetts, United States

    Contact: Study coordinator (Sara Schiller) · sara.schiller1@umassmed.edu · 774-548-1090
    Contact: Principal Investigator (Elisa Franquet-Elia, MD)

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Kera Delaney) · delaney.kera@mayo.edu · 507-293-2227
    Contact: Principal Investigator (Ajit H Goenka, MD)

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Ilda Bander) · Ilda.bander@mountsinai.org · 212-241-0763
    Contact: Principal Investigator (Sampanna Rayamajhi, MD)

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Jordayna Francois) · francoij@mskcc.org · (646)888-6819
    Contact: Principal Investigator (Aria Razmari, MD)

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Molly Haberkorn) · HABERKS@ccf.org · 216-445-6434
    Contact: Principal Investigator (Nicholas Austin, DO)

  • Kettering, Kettering, Ohio, United States

    Contact: Study coordinator (Kathren Garber) · kathren.garber@ketteringhealth.org · 937-395-8390
    Contact: Principal Investigator (Arif Sheikh, MD)

  • University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Erin Schubert) · Erin.schubert@pennmedicine.upenn.edu · 215-573-6569
    Contact: Principal Investigator (Mark Sellmyer, MD, PhD)
מובילי המחקר

  • Sherly Mosessian, Ph.D

    Study Director

    Sofie Co.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)